Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Arsenic Trioxide and Sulforaphane

Research Papers that Mention the Interaction

ATO and sulforaphane co-treatment augmented apoptotic induction as demonstrated by cleavage of caspase-3, -4 and PARP.
Like BTZ, sulforaphane synergistically enhances the cytotoxicity of arsenic trioxide ( ATO), an agent with clinical activity in MM.
Our results suggest that sulforaphane deserves further investigation in combination with ATO in the treatment of MM.
Sulforaphane in combination with ATO effectively disrupts protein homeostasis through ROS generation and induction of ER stress to culminate in inhibition of protein secretion and apoptotic induction in MM.
Oncology reports  •  2012  |  View Paper
Cellular exposure to sulforaphane in combination with ATO resulted in a dramatic increase in levels of reactive oxygen species (ROS) compared to treatment with either agent alone.
Leukemia research  •  2010  |  View Paper